# A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine

> **NCT00343681** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 120 (actual)

## Conditions studied

- Influenza
- Orthomyxoviridae Infections

## Interventions

- **BIOLOGICAL:** Inactivated influenza vaccine (split virion)

## Key facts

- **NCT ID:** NCT00343681
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343681, "A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00343681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*